Intelerad CEO Jordan Bazinsky outlines how advanced technology and strategic partnerships can help medical imaging withstand financial, regulatory, and workforce pressures.
Key Details
- 1Medicare radiology reimbursement declined 3.4% in 2024 and 2.83% in 2025, part of a 25% decrease since 2005.
- 2FDA staff reductions may delay imaging device and AI tool approvals, affecting innovation availability.
- 3Radiologist workforce shortage persists; ARRT exam takers fell 18% between 2006 and 2022, with demand for CT and MRI rising 3-5% yearly.
- 4AI, integrated platforms, telehealth, and compliance tools are recommended to improve efficiency, care coordination, and regulatory adherence.
- 5Collaborations with vendors and academic institutions can mitigate outsourcing and strengthen the radiologist pipeline.
Why It Matters

Source
AuntMinnie
Related News

Capitol Imaging Adopts AI to Streamline Outpatient Radiology Operations
Capitol Imaging Services is leveraging AI-powered RIS and automation tools to enhance scheduling and front-office efficiency across its imaging centers.

GE HealthCare’s True Definition DL Receives FDA Clearance for CT Imaging
GE HealthCare's True Definition DL, a deep learning-based CT image reconstruction tool, has received FDA 510(k) clearance.

Lucida Medical Raises $11M for AI-Based Prostate MRI Diagnosis Expansion
Lucida Medical, specializing in AI-assisted prostate cancer diagnosis via MRI, raises $11.4M to drive US FDA approval and platform expansion.